LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Generated: 2026-11-22
Case ID: NM_002691.4_c.242G_A_20261122_172908
Framework: ACMG/AMP 2015
Variant classification summary

NM_002691.4:c.242G>A

POLD1  · NP_002682.2:p.(Arg81Gln)  · NM_002691.4
GRCh37: chr19:50902667 G>A  ·  GRCh38: chr19:50399410 G>A
Gene: POLD1 Transcript: NM_002691.4
Final call
VUS
PM2 moderate
All criteria require review: For research and educational purposes only.
Gene
POLD1
Transcript
NM_002691.4
Protein
NP_002682.2:p.(Arg81Gln)
gnomAD AF
6.195748477394812e-06 (v4.1)
ClinVar
Uncertain significance
OncoKB
Unknown Oncogenic Effect
Interpretation summary
Generated evidence synthesis
1
PM2 Moderate: gnomAD v4.1 allele frequency is 6.19575e-06, below the 0.0001 cutoff.
Final determination: Under generic ACMG/AMP 2015 rules, one Moderate criterion alone satisfies no pathogenic, likely pathogenic, benign, or likely benign combination, so the result is VUS.
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
Criterion Status Rationale Evidence used
PVS1 N/A Not applicable: PVS1 requires a null variant (nonsense, frameshift, canonical splice, start-loss or stop-loss), and this is a missense variant.
pvs1_generic_framework generic_acmg_combination_rules
PS1 Not assessed Not assessed: no previously established pathogenic Arg81Gln variant from a different nucleotide change is documented; ClinVar classifies this variant as uncertain significance.
clinvar
PS2 Not assessed Not assessed: no documented proband phenotype, family-history status, or confirmed maternity and paternity is available for this variant.
clinvar
PS3 Not assessed Not assessed: no variant-specific validated in vitro or in vivo functional assay, controls, or reproducibility data were identified for POLD1 c.242G>A (p.Arg81Gln).
PMID:25741868
PS4 Not assessed Not assessed: no exact-variant case-control counts, odds ratio, or confidence interval were reported, so the PS4 requirement of OR/RR >5.0 cannot be evaluated.
PMID:25394175 PMID:33850299 PMID:29056344 PMID:29950348 PMID:25741868
PM1 Not assessed Not assessed: POLD1 R81 is outside the reported codons 245-571 proofreading domain and no hotspot was found, but a complete critical-domain assessment is unavailable.
hotspots PMID:29950348
PM2 Met Met at Moderate: gnomAD v4.1 total AF is 6.19575e-06, below the 0.0001 PM2 extremely-low-frequency cutoff.
gnomad_v4 gnomad_v2 PMID:25741868
PM3 Not assessed Not assessed: no affected-proband observation or parental/offspring testing establishes this variant in trans with a pathogenic variant.
clinvar
PM4 N/A Not applicable: PM4 requires a protein-length change, and this is a missense variant.
pvs1_generic_framework generic_acmg_combination_rules
PM5 Not met Not met: the p.Arg81Gln comparator search found zero same-residue candidates and zero pathogenic same-residue missense comparators.
pm5_candidates clinvar
PM6 Not assessed Not assessed: no assumed de novo occurrence or parental testing is documented for NM_002691.4:c.242G>A.
clinvar
PP1 Not assessed Not assessed: zero affected relatives and zero informative meioses are documented for segregation of this variant.
PP2 Not assessed Not assessed: no gene-wide benign-missense rate and no evidence establishing missense variants as a common POLD1 disease mechanism are supplied.
PP3 Not met Not met: missense REVEL score 0.307 is below the PP3 supporting threshold of >=0.644.
revel PMID:25741868
PP4 Not assessed Not assessed: the available evidence gives no patient phenotype or family-history details demonstrating a highly specific single-gene disease presentation.
PP5 Not met Not met: ClinVar has zero expert-panel submissions and all five exact-variant laboratory submissions classify POLD1 c.242G>A as uncertain significance.
clinvar PMID:25394175 PMID:33850299 PMID:25741868
BA1 Not met Not met: gnomAD v4.1 grpmax FAF is 2.47e-06, far below the 0.05 BA1 stand-alone threshold.
gnomad_v4 gnomad_v2 PMID:25741868
BS1 Not met Not met: gnomAD v4.1 grpmax FAF is 2.47e-06, below the generic BS1 threshold of 0.01.
gnomad_v4 gnomad_v2
BS2 Not assessed Not assessed: gnomAD allele counts do not document a healthy adult carrier, age, phenotype exclusion, inheritance, or full penetrance.
gnomad_v4 gnomad_v2
BS3 Not assessed Not assessed: no variant-specific validated assay demonstrated that POLD1 c.242G>A (p.Arg81Gln) has no damaging effect on protein function or splicing.
PMID:25741868
BS4 Not assessed Not assessed: no affected relatives tested negative for NM_002691.4:c.242G>A are documented.
BP1 Not assessed Not assessed: available evidence documents POLD1 missense disease associations but does not quantify whether disease is caused primarily by truncating variants.
PMID:29950348
BP2 Not assessed Not assessed: no parental, offspring, or haplotype data establish this variant in trans or cis with a pathogenic variant.
clinvar
BP3 N/A Not applicable: BP3 requires an in-frame indel in a repeat region, and this is a missense variant.
pvs1_generic_framework generic_acmg_combination_rules
BP4 Not met Not met: missense REVEL score 0.307 exceeds the BP4 supporting threshold of <=0.29.
revel PMID:25741868
BP5 Not assessed Not assessed: no exact-variant case evidence shows an alternate molecular basis for the patient's disease.
clinvar PMID:25394175 PMID:33850299
BP6 Not met Not met: ClinVar has zero expert-panel submissions and no exact-variant Benign or Likely benign expert-panel classification.
clinvar
BP7 N/A Not applicable: BP7 requires a synonymous variant, and this is a missense variant.
generic_acmg_combination_rules
Disclaimer: The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.